Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:combination_drug
|
| gptkbp:approvedBy |
gptkb:Brazil
gptkb:India |
| gptkbp:ATCCode |
P01BF02
|
| gptkbp:combinationType |
fixed-dose combination
|
| gptkbp:contains |
gptkb:artesunate
gptkb:mefloquine |
| gptkbp:developedBy |
gptkb:Plasmodium_falciparum_malaria
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
gptkb:antimalarial
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting dizziness insomnia |
| gptkbp:usedFor |
malaria
|
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:WHOPrequalified |
yes
|
| gptkbp:bfsParent |
gptkb:artemisinin-based_combination_therapies_(ACTs)
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
artesunate-mefloquine
|